Health Canada says rapid blood test for COVID-19 remains under review

A scientist presents an antibody test for coronavirus in a laboratory in Jena, Germany. BTNX Inc., a Canadian company that makes the same kind of rapid-response blood test to detect coronavirus antibodies, has been told its test is not ready for the Canadian market. 
The Associated Press

Date Published: April 13, 2020

Source: CBC

Unlike other countries such as the US, UK and many in Europe, Health Canada has yet to approve the use of a 15 minute 10$ blood test that detects the presence of antibodies that fight the COVID-19 virus. While they can’t detect the virus early, as nasal swabs do, the rapid blood tests diagnose patients a week after symptoms appear, once the patient produces antibodies. This can identify those who are immune putting them back to work and in front line patient care as Germany and South Korea have done. Although there has been a big push to skip typical regulation approval steps, Health Canada has been adamant in “validat[ing] testing and research, along with expert advice, so that [they] can have confidence in the test results.”

Read the full article here:

Summary by: Mark Youssef